Stopping clinical trials early for benefit: Impact on estimation

Clinical Trials

Volumn 6, Issue 2, 2009, Pages 119-125

  Freidlin, Boris ^a,b   Korn, Edward L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Biometric Research Branch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CONFIDENCE INTERVAL; CONTROLLED STUDY; HAZARD RATIO; INTERMETHOD COMPARISON; PRIORITY JOURNAL; SAMPLE SIZE; SIMULATION; SYSTEMATIC ERROR;

CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; DECISION MAKING; HUMANS; RESEARCH DESIGN; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 65249135552     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774509102310     Document Type: Article

References (21)

1. Montori VM, Devereaux PH, Adhikari NKJ et al. Randomized trials stopped early for benefit: A systematic review. JAMA 2005; 294: 2203-209.
2. Mueller PS, Montori VM, Bassler D. et al. Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med 2007; 146: 878-81.
3. Bassler D., Montori VM, Briel M. et al. Early stopping of randomized clinical trials for overt efficacy is problematic. J Clin Epidemiol 2008; 61: 241-6.
4. Wilcox RA, Djulbegovic B., Guyatt GH et al. Randomized trials in oncology stopped early for benefit. J Clin Oncol 2008; 26: 18-9.
5. Pocock SJ, Hughes MD Practical problems in interim analyses, with particular regard to estimation. Control Clin Trials 1989; 10: 209S-21S.
6. Chang MN, Wieand HS, Chang VT The bias of the sample proportion following a group sequential phase II clinical trial. Stat Med 1989; 8: 563-70.
7. Goodman SN Stopping at nothing? Some dilemmas of data monitoring in clinical trials. Ann Intern Med 2007; 146: 882-7.
8. Whitehead J. On the bias of maximum-likelihood-estimation following a sequential test. Biometrika 1986; 73: 573-81.
9. Emerson SS, Fleming TR Parameter estimation following group sequential hypothesis-testing. Biometrika 1990; 77: 875-92.
10. Todd S., Whitehead J., Facey KM Point and interval estimation following a sequential clinical trial. Biometrika 1996; 83: 453-61.
11. Fan X., DeMets DL, Lan KKG. Conditional bias of point estimates following a group sequential test. J Biopharm Stat 2004; 14: 505-30.
12. Tsiatis AA, Rosner GL, Mehta CR Exact confidence intervals following a group sequential test. Biometrics 1984; 40: 797-803.
13. Jennison C., Turnbull BW Group Sequential Methods with Applications to Clinical Trials. Chapman & Hall/CRC, Boca Raton, 2000.
14. O'Brien PC, Fleming TR A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549-56.
15. Haybittle JL Repeated assessment of results in clinical trials of cancer treatment. Br J Radiol 1971; 44: 793-7.
16. Peto R., Pike MC, Armitage P. et al. Design and analysis of randomized clinical trials requiring prolonged observation or each patient. Br J Cancer 1976; 34: 585-612.
17. Pocock SJ When (not) to stop a clinical trial for benefit. JAMA 2005; 294: 2228-30.
18. Freidlin B., Korn EL Monitoring for lack of benefit: A critical component of a randomized clinical trial. J Clin Oncol, published online December 8, 2008, 10.1200/JCO.2008.17.8905.
19. Spiegelhalter DJ, Freedman LS, Parmar MKB. Bayesian approaches to randomized trials. J R Stat Soc, [Ser A] 1994; 157: 357-87.
20. Ohman Strickland PA, Casella G. Conditional inference following group sequential testing. Biom J 2003; 5: 515-26.
21. Korn EL, Freidlin B., Mooney M. Stopping or reporting early for positive results in randomized clinical trials: The NCI cooperative group experience 1990-2005. J Clin Oncol 2009, In press.